JXSB2400023 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Supplementary Application | 2024-03-04 | | | | | view |
JXSB2400011 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Supplementary Application | 2024-02-02 | | | | | view |
JXSL2400011 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Import Drug Application | 2024-01-10 | | | | | view |
JXSB2300103 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Supplementary Application | 2023-08-24 | | | | | view |
JXSL2300149 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Import Drug Application | 2023-08-02 | | | | | view |
JXSB2300086 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Supplementary Application | 2023-07-08 | | | | | view |
JXSB2300066 | 注射用德曲妥珠单抗(DS-8201a) | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Supplementary Application | 2023-05-31 | | | | | view |
JXSB2200120 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Supplementary Application | 2022-09-19 | | | | | view |
JXSB2200068 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Supplementary Application | 2022-06-13 | | | | | view |
JXSB2200044 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Supplementary Application | 2022-04-22 | | | | | view |
JXSB2200012 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Supplementary Application | 2022-01-25 | | | | | view |
JXSB2101102 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Supplementary Application | 2021-12-07 | | | | | view |
JXSB2101068 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Supplementary Application | 2021-10-19 | | | | | view |
JTS2100530 | Trastuzumab deruxtecan (DS-8201a, T-DXd ) 原液 | trastuzumab deruxtecan | Lyophilized | Biological Products | Disposable Import Drug Application | 2021-10-11 | | | | | view |
JTS2100529 | 注射用Trastuzumab deruxtecan (DS-8201a, T-DXd ) | trastuzumab deruxtecan | Lyophilized | Biological Products | Disposable Import Drug Application | 2021-10-11 | | | | | view |
JXSL2101093 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Import Drug Application | 2021-08-13 | | | | | view |
JXSL2101086 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Import Drug Application | 2021-08-03 | | | | | view |
JXSL2101064 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Import Drug Application | 2021-07-02 | | | | | view |
JXSB2101024 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Supplementary Application | 2021-06-15 | | | | | view |
JXSL2100011 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Import Drug Application | 2021-01-25 | Daiichi Sankyo, Inc. | Daiichi Sankyo Co Ltd | In Review | 2021-01-25 | view |